Citrotech / General Enterprise Ventures, Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2023. The filing names General Enterprise Ventures, Inc. (GEVI) as the registrant; it describes CitroTech products within its Mighty Fire Breaker business. This differs from the requested company name, Citrotech Inc., and should be verified.
Business context and key results
GEVI describes itself as a technology company focused on acquiring and developing businesses. Its reported operating revenue is from Mighty Fire Breaker, LLC (MFB), whose fire-prevention products use the CitroTech name. The company divested its crypto-mining operations in 2022.
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $174,710 | $19,033 | $258,660 | $60,501 |
| Gross profit | $134,827 | $17,235 | $200,030 | $58,703 |
| Gross margin | 77.2% | 90.6% | 77.3% | 97.0% |
| Operating expenses | $9,156,070 | $314,224 | $9,930,183 | $2,717,531 |
| Net loss | $9,023,003 | $297,065 | $9,732,672 | $2,647,918 |
| Operating cash flow | Not separately provided | Not separately provided | $(819,936) | $(506,731) |
Gross margins are calculated from reported revenue and gross profit. The nine-month 2023 operating expenses included $8.64 million of noncash stock-based professional fees to a related party and $180,000 of stock compensation for shares to be issued to two directors. Stock-based compensation totaled $8.97 million for the nine months. The large increase in reported losses primarily reflects these noncash charges.
Financial position, liquidity, and financing
- At September 30, 2023, cash was $565,867, current assets were $947,683, and current liabilities were $1,722,087, resulting in a working-capital deficit of $774,404.
- Total liabilities were $1,793,011, including $1,407,681 due to related parties under unsecured, non-interest-bearing demand arrangements; $54,000 of convertible notes; a $120,000 promissory note; and $149,174 of operating lease liabilities.
- The convertible notes are reported as in default. They carry 2% interest and are convertible at the lender’s option at $0.18 per common share. The promissory note bears 5% interest and has a 12-month term.
- Nine-month financing cash inflows of $1,332,600 included $305,000 in related-party loans, $907,600 from Series C preferred stock subscriptions, and $120,000 from a promissory note. Cash rose from $55,434 at year-end 2022 to $565,867.
- Intangible assets were $4,195,353, primarily representing MFB intellectual property acquired in 2022. Operating cash flow remained negative; the filing says the company has not generated positive operating cash flow.
Material changes, outlook, and risks
- Revenue increased year over year, but remains modest; one customer represented 66% of nine-month 2023 revenue and 100% of period-end accounts receivable. One supplier represented 96% of purchases.
- Series C preferred shares outstanding increased to 2,273,499 from 950,000. The shares convert into 20 common shares each. The filing also reports 97,545,388 common shares outstanding at September 30 and November 13, 2023.
- The company issued 1,200,000 Series C preferred shares to a related-party consultant for services, valued at $8.64 million using an assumed common-stock conversion basis. Separately, 70 million restricted common shares issued to the president remain subject to revenue targets of at least $100 million in each of 2023–2026. The filing provides no quantified sales or earnings guidance.
- Management states that the company’s limited operating capital and lack of significant income raise substantial doubt about its ability to continue as a going concern; continued operations depend on raising capital and generating revenue and profits.
- Management concluded disclosure controls were ineffective, citing no functioning audit committee, insufficient independent-director oversight, inadequate segregation of duties, and management concentration in one individual. It warns that financial-statement errors or restatements may occur.
- MFB’s acquisition vendor is entitled to a 10% royalty on gross sales of the MFB product family. Management reports no legal proceeding expected to have a material adverse effect.
- Management describes product testing, certifications, and commercial efforts, but the filing does not provide a quantified forecast. Its patent and product-status descriptions vary within the filing; commercial traction and the status of claimed approvals should be checked.
Important facts for investors to verify
- Whether this GEVI filing is the intended filing for Citrotech Inc., and the relationship between the entities and CitroTech/MFB operations.
- The terms, balances, maturity/default status, and repayment expectations for related-party obligations and convertible notes.
- The valuation and related-party approval process for the $8.64 million preferred-stock consulting award, plus its potential dilution and the director share issuance.
- Customer and supplier dependence, collectability of the $182,308 receivable, and evidence of recurring revenue growth and cash generation.
- Management’s financing plans to address the going-concern uncertainty and actions to remediate material weaknesses in controls.
- Actual product approvals, testing status, patent portfolio, and progress toward the restricted-share revenue thresholds.